Maipomycin A, a Novel Natural Compound With Promising Anti-biofilm Activity Against Gram-Negative Pathogenic Bacteria
Authors:
Open Access
- 12 January 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 11
Abstract
Pathogenic bacterial biofilms play an important role in recurrent nosocomial and medical device-related infections. Once occurred, the complex structure of the biofilm promotes the development of antibiotic resistance and becomes extremely difficult to eradicate. Here we describe a novel and effective anti-biofilm compound maipomycin A (MaiA), which was isolated from the metabolites of a rare actinomycete strain Kibdelosporangium phytohabitans XY-R10. Its structure was deduced from analyses of spectral data and confirmed by single-crystal X-ray crystallography. This natural product demonstrated a broad spectrum of anti-biofilm activities against Gram-negative bacteria. Interestingly, the addition of Fe(II) or Fe(III) ions could block the biofilm inhibition activity of MaiA because it is an iron chelator. However, not all iron chelators showed biofilm inhibition activity, suggesting that MaiA prevents biofilm formation through a specific yet currently undefined pathway. Furthermore, MaiA acts as a synergist to enhance colistin efficacy against Acinetobacter baumannii. Our results indicate that MaiA may potentially serve as an effective antibiofilm agent to prevent Gram-negative biofilm formation in future clinical applications.Keywords
This publication has 44 references indexed in Scilit:
- Antibacterial Activities of Iron Chelators against Common Nosocomial PathogensAntimicrobial Agents and Chemotherapy, 2012
- Anti-biofilm activity of an exopolysaccharide from a sponge-associated strain of Bacillus licheniformisMicrobial Cell Factories, 2011
- Antibiofilm Activity of an Exopolysaccharide from Marine Bacterium Vibrio sp. QY101PLOS ONE, 2011
- Acquired bloodstream infection in the intensive care unit: incidence and attributable mortalityCritical Care, 2011
- The biofilm matrixNature Reviews Microbiology, 2010
- Tobramycin and FDA-Approved Iron Chelators Eliminate Pseudomonas aeruginosa Biofilms on Cystic Fibrosis CellsAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- Iron-binding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditionsJournal of Medical Microbiology, 2009
- An increasing threat in hospitals: multidrug-resistant Acinetobacter baumanniiNature Reviews Microbiology, 2007
- Broad-spectrum biofilm inhibition by a secreted bacterial polysaccharideProceedings of the National Academy of Sciences, 2006
- Iron and microbial infectionNature Reviews Microbiology, 2004